» Articles » PMID: 33228112

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Nov 24
PMID 33228112
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Downstream neighbor of Son (DONSON) plays a crucial role in cell cycle progression and in maintaining genomic stability, but its role in prostate cancer (PCa) development and progression is still underinvestigated. Methods: DONSON mRNA expression was analyzed with regard to clinical-pathological parameters and progression using The Cancer Genome Atlas (TCGA) and two publicly available Gene Expression Omnibus (GEO) datasets of PCa. Afterwards, DONSON protein expression was assessed via immunohistochemistry on a comprehensive tissue microarray (TMA). Subsequently, the influence of a DONSON-knockdown induced by the transfection of antisense-oligonucleotides on proliferative capacity and metastatic potential was investigated. DONSON was associated with an aggressive phenotype in the PCa TCGA cohort, two GEO PCa cohorts, and our PCa TMA cohort as DONSON expression was particularly strong in locally advanced, metastasized, and dedifferentiated carcinomas. Thus, DONSON expression was notably upregulated in distant and androgen-deprivation resistant metastases. In vitro, specific DONSON-knockdown significantly reduced the migration capacity in the PCa cell lines PC-3 and LNCaP, which further suggests a tumor-promoting role of DONSON in PCa. In conclusion, the results of our comprehensive expression analyses, as well as the functional data obtained after DONSON-depletion, lead us to the conclusion that DONSON is a promising prognostic biomarker with oncogenic properties in PCa.

Citing Articles

DONSON is required for CMG helicase assembly in the mammalian cell cycle.

Evrin C, Alvarez V, Ainsworth J, Fujisawa R, Alabert C, Labib K EMBO Rep. 2023; 24(11):e57677.

PMID: 37781960 PMC: 10626419. DOI: 10.15252/embr.202357677.


DONSON facilitates Cdc45 and GINS chromatin association and is essential for DNA replication initiation.

Kingsley G, Skagia A, Passaretti P, Fernandez-Cuesta C, Reynolds-Winczura A, Koscielniak K Nucleic Acids Res. 2023; 51(18):9748-9763.

PMID: 37638758 PMC: 10570026. DOI: 10.1093/nar/gkad694.


Imaging the cellular response to an antigen tagged interstrand crosslinking agent.

Bellani M, Huang J, Zhang J, Gali H, Thazhathveetil A, Pokharel D DNA Repair (Amst). 2023; 128:103525.

PMID: 37320956 PMC: 10413329. DOI: 10.1016/j.dnarep.2023.103525.


Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers.

von Danwitz M, Klumper N, Bernhardt M, Cox A, Krausewitz P, Alajati A Cancers (Basel). 2023; 15(6).

PMID: 36980776 PMC: 10046786. DOI: 10.3390/cancers15061890.


Downstream Neighbor of Son Overexpression is Associated With Breast Cancer Progression and a Poor Prognosis.

Qi Y, Wu H, Liu C, Zheng D, Yan C, Hu W J Breast Cancer. 2022; 25(4):327-343.

PMID: 35914745 PMC: 9411031. DOI: 10.4048/jbc.2022.25.e26.


References
1.
Chandran U, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W . Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer. 2007; 7:64. PMC: 1865555. DOI: 10.1186/1471-2407-7-64. View

2.
Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

3.
Yamada Y, Nohata N, Uchida A, Kato M, Arai T, Moriya S . Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma. Cancer Sci. 2020; 111(4):1392-1406. PMC: 7156888. DOI: 10.1111/cas.14327. View

4.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

5.
Taylor B, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver B . Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. PMC: 3198787. DOI: 10.1016/j.ccr.2010.05.026. View